Annual EBITDA
-$298.59M$198.19M+39.89%
Summary
- Current Value
- As of today, MDGL annual EBITDA is -$298.59M, up +39.89% on
- Historical Performance
- MDGL annual EBITDA is down -1.87% over the past 3 years, down -45.05% over the past 5 years
- All-Time High Comparison
- MDGL annual EBITDA is currently -459.74% below its historical high of $83.00M set on
- 3-Year Low Comparison
- MDGL annual EBITDA is +39.89% above its 3-year low of -$496.78M reached on
- Sector Comparison
- MDGL annual EBITDA is higher than 4.39% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$298.59M | +39.9% | -1.9% | -45.0% | -754.0% | |
| Quarterly EBITDA | -$55.93M | -19.4% | +35.2% | +9.3% | -381.1% | |
| TTM EBITDA | -$321.10M | -4.1% | +2.7% | -38.0% | -706.5% | |
| Price | $530.57 | +51.8% | +209.5% | +526.7% | +260.9% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $958.40M | +432.1% | +100.0% | +100.0% | +6374.4% | |
| Annual EPS | -$12.85 | +41.3% | +25.4% | +1.9% | +60.5% | |
| -$300.10M | +39.7% | -2.2% | -45.5% | -713.3% | ||
| Annual Net Income | -$288.28M | +38.1% | +2.4% | -42.5% | -669.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$293.10M | N/A | -1.9% |
| 5Y | -$205.85M | N/A | -45.0% |
| All | $83.00M | -459.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$496.78M | +39.9% | |
| 5Y | -$496.78M | +39.9% | |
| All | -$496.78M | +39.9% |
EBITDA History
FAQ
- What is the current annual EBITDA of MDGL?
- As of today, MDGL annual EBITDA is -$298.59M
- What is 1-year change in MDGL annual EBITDA?
- MDGL annual EBITDA is up +39.89% year-over-year
- What is 3-year change in MDGL annual EBITDA?
- MDGL annual EBITDA is down -1.87% over the past 3 years
- How far is MDGL annual EBITDA from its all-time high?
- MDGL annual EBITDA is currently -459.74% below its historical high of $83.00M set on December 31, 2009
- How does MDGL annual EBITDA rank versus sector peers?
- MDGL annual EBITDA is higher than 4.39% of companies in Healthcare sector
- When is MDGL next annual earnings release?
- As of today, the next annual earnings release for MDGL has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
-$55.93M$36.41M+39.43%
Summary
- Current Value
- As of today, MDGL quarterly EBITDA is -$55.93M, up +39.43% on
- Historical Performance
- MDGL quarterly EBITDA is down -19.44% year-over-year, up +35.21% over the past 3 years
- All-Time High Comparison
- MDGL quarterly EBITDA is currently -147.09% below its historical high of $118.78M set on
- 3-Year Low Comparison
- MDGL quarterly EBITDA is +65.53% above its 3-year low of -$162.27M reached on
- Sector Comparison
- MDGL quarterly EBITDA is higher than 7.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$55.93M | +39.4% | -19.4% | +35.2% | +9.3% | |
| Annual EBITDA | -$298.59M | – | +39.9% | -1.9% | -45.0% | |
| TTM EBITDA | -$321.10M | -2.9% | -4.1% | +2.7% | -38.0% | |
| Price | $530.57 | +6.8% | +51.8% | +209.5% | +526.7% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $364.25M | +17.0% | +71.2% | +100.0% | +100.0% | |
| Quarterly EPS | -$1.99 | +38.9% | -4.4% | +57.6% | +46.6% | |
| -$56.31M | +39.3% | -19.3% | +34.9% | +8.8% | ||
| Quarterly Net Income | -$57.94M | +38.6% | -37.0% | +32.5% | +6.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$46.83M | N/A | -19.4% |
| 3Y | -$46.83M | -19.4% | |
| 5Y | -$46.83M | -19.4% | |
| All | $118.78M | -147.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$113.62M | +50.8% | |
| 3Y | -$162.27M | +65.5% | |
| 5Y | -$162.27M | +65.5% | |
| All | -$162.27M | +65.5% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of MDGL?
- As of today, MDGL quarterly EBITDA is -$55.93M
- What is MDGL quarterly EBITDA most recent change?
- MDGL quarterly EBITDA was up +39.43% on June 30, 2026
- What is 1-year change in MDGL quarterly EBITDA?
- MDGL quarterly EBITDA is down -19.44% year-over-year
- How far is MDGL quarterly EBITDA from its all-time high?
- MDGL quarterly EBITDA is currently -147.09% below its historical high of $118.78M set on September 30, 2009
- How does MDGL quarterly EBITDA rank versus sector peers?
- MDGL quarterly EBITDA is higher than 7.62% of companies in Healthcare sector
- When is MDGL next earnings release?
- The next earnings release for MDGL is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$321.10M$9.10M-2.92%
Summary
- Current Value
- As of today, MDGL TTM EBITDA is -$321.10M, down -2.92% on
- Historical Performance
- MDGL TTM EBITDA is down -4.12% year-over-year, up +2.70% over the past 3 years
- All-Time High Comparison
- MDGL TTM EBITDA is currently -435.29% below its historical high of $95.77M set on
- 3-Year Low Comparison
- MDGL TTM EBITDA is +41.32% above its 3-year low of -$547.18M reached on
- Sector Comparison
- MDGL TTM EBITDA is higher than 3.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$321.10M | -2.9% | -4.1% | +2.7% | -38.0% | |
| Annual EBITDA | -$298.59M | – | +39.9% | -1.9% | -45.0% | |
| Quarterly EBITDA | -$55.93M | +39.4% | -19.4% | +35.2% | +9.3% | |
| Price | $530.57 | +6.8% | +51.8% | +209.5% | +526.7% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $1.28B | +13.4% | +149.0% | +100.0% | +100.0% | |
| TTM EPS | -$12.88 | -0.7% | -0.3% | +30.9% | +11.8% | |
| -$322.62M | -2.9% | -4.1% | +2.4% | -38.4% | ||
| TTM Net Income | -$325.10M | -5.1% | -15.3% | +1.4% | -40.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$298.59M | -7.5% | |
| 3Y | -$298.59M | -7.5% | |
| 5Y | -$232.63M | N/A | -38.0% |
| All | $95.77M | -435.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$321.10M | at low | |
| 3Y | -$547.18M | +41.3% | |
| 5Y | -$547.18M | +41.3% | |
| All | -$547.18M | +41.3% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of MDGL?
- As of today, MDGL TTM EBITDA is -$321.10M
- What is MDGL TTM EBITDA most recent change?
- MDGL TTM EBITDA was down -2.92% on June 30, 2026
- What is 1-year change in MDGL TTM EBITDA?
- MDGL TTM EBITDA is down -4.12% year-over-year
- How far is MDGL TTM EBITDA from its all-time high?
- MDGL TTM EBITDA is currently -435.29% below its historical high of $95.77M set on March 31, 2010
- How does MDGL TTM EBITDA rank versus sector peers?
- MDGL TTM EBITDA is higher than 3.90% of companies in Healthcare sector
- When is MDGL next earnings release?
- The next earnings release for MDGL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl